Financial News
All News about Revance Therapeutics
![](https://cdn.benzinga.com/files/images/story/2022/09/09/aapharma_9.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_26388.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_357.png?width=1200&height=800&fit=crop)
Needham Maintains Buy Rating for Revance Therapeutics: Here's What You Need To Know
September 09, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_26289.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_26282.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/08/bz-pharma_2.jpg?width=1200&height=800&fit=crop)
Important Biotech Catalysts For September 8, 2022 - End Of The Day Summary
September 08, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/08/10/aapharma_16.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_618.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_6230.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/09/image17.jpg?width=1200&height=800&fit=crop)
Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday
September 09, 2022
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/06/aapl-1600.png)
![](https://cdn.benzinga.com/files/images/story/2022/09/08/image24.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/09/rvnc1600.png)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_16516.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/08/bz-pharma.jpg?width=1200&height=800&fit=crop)
Revance Shares Shoot Higher As FDA Cleared DAXXIFY Injection For Frown Lines
September 08, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/08/image28.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220908005320/en/1565360/5/Product_Shot_2_DAXXIFY%E2%84%A2_%28daxibotulinumtoxinA-lanm%29_for_injection.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/options_image_1965.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/31/biotech6.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/options_image_1822.jpeg?width=1200&height=800&fit=crop)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_8210.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_4467.jpeg?width=1200&height=800&fit=crop)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/images/story/2022/roce_image_1816.jpeg?width=1200&height=800&fit=crop)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/images/story/2022/05/10/analysis-gea8109339_1920.jpg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.